Family Medicine & Primary Care Review

Full text

2/2026 vol. 28
Review paper

Hepatitis A in Poland: a review of current epidemiological data

Joanna Jarzębska 1
,
Jakub Marek Baran 2
,
Damian Grusiecki 3
,
Zuzanna Waszak 4, 5
,
Maja Śmigielska 2
,
Maria Piotrowicz 6

  1. Military Institute of Medicine – National Research Institute, Warsaw, Poland

  2. Bielański Hospital, Warsaw, Poland

  3. Miedzylesie Specialist Hospital, Warsaw, Poland

  4. Praski Hospital, Warsaw, Poland

  5. Students' Scientific Circle of Hygiene and Prevention, Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland

  6. Department of Health Promotion and Public Health System Implementation, Warsaw, Poland

Family Medicine & Primary Care Review 2026; 28(2): 193–199

DOI: https://doi.org/10.5114/fmpcr.2026.161841
Data publikacji online: 2026/06/22
Article file
14 FM&PCR 2 26 - R - Jarzębska - 2062 - Hepatitis A.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. World Health Organization. Hepatitis A 2025 [cited 23.04.2026]. Available from URL: https://www.who.int/news-room/fact-sheets/detail/hepatitis-a.
  2. World Health Organization. WHO immunological basis for immunization series: module 18: hepatitis A, update 2019. Geneva: WHO; 2019.
  3. Patterson J, Abdullahi L, Hussey GD, et al. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis 2019; 19: 651, doi: 10.1186/s12879-019-4235-5.
  4. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132: 1005–1022, doi: 10.1017/S0950268804002857.
  5. World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. Geneva: WHO; 2010.
  6. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28: 6653–6657, doi: 10.1016/j.vaccine.2010.08.037.
  7. Carrillo-Santisteve P, Tavoschi L, Severi E, et al. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. Lancet Infect Dis 2017; 17: e306–e319, doi: 10.1016/S1473-3099(17)30392-4.
  8. World Health Organization. Hepatitis A. Geneva: WHO; 2018.
  9. European Centre for Disease Prevention and Control. Disease information about hepatitis A 2017 [cited 23.04.2026]. Available from URL: https://www.ecdc.europa.eu/en/hepatitis-a.
  10. Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses 2021; 13: 1900, doi: 10.3390/v13101900.
  11. Ndumbi P, Freidl GS, Williams CJ, et al. Hepatitis A outbreak disproportionately affecting men who have sex with men in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveill 2018; 23: 1700641, doi: 10.2807/1560-7917.ES.2018.23.33.1700641.
  12. Raczyńska A, Wickramasuriya NN, Kalinowska-Nowak A, et al. Acute hepatitis A outbreak among men who have sex with men in Krakow, Poland; February 2017–February 2018. Am J Mens Health 2019; 13: 1557988319895141, doi: 10.1177/1557988319895141.
  13. Franco E. Hepatitis A: epidemiology and prevention in developing countries. World J Hepatol 2012; 4: 68–73, doi: 10.4254/wjh.v4.i3.68.
  14. Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med 2018; 8(10): a031716, doi: 10.1101/cshperspect.a031716.
  15. Lemon SM, Ott JJ, Van Damme P, et al. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol 2018; 68: 167–184, doi: 10.1016/j.jhep.2017.08.034.
  16. Girish V, Grant LM, John S. Hepatitis A. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Oct [cited 23.04.2026]. Available from URL: https://www.ncbi.nlm.nih.gov/books/NBK459290/.
  17. Zhang L, Wang T, Zhou S, et al. Update on the global burden of acute viral hepatitis in 2021: addressing health inequalities. Front Public Health 2025; 13: 1580863, doi: 10.3389/fpubh.2025.1580863.
  18. European Centre for Disease Prevention and Control. Hepatitis A. Stockholm: ECDC; 2019. Available from URL: https://www.ecdc.europa.eu/en/publications-data/hepatitis-annual-epidemiological-report-2019.
  19. European Centre for Disease Prevention and Control. Hepatitis A. Stockholm: ECDC; 2023. Available from URL: https://www.ecdc.europa.eu/sites/default/files/documents/HEPA_AER_2022_Report.pdf
  20. European Centre for Disease Prevention and Control. Rapid risk assessment: multi-country outbreak of hepatitis A in the EU/EEA 2025 [cited 20.04.2026]. Available from URL: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-multi-country-outbreak-hepatitis-eueea.
  21. National Institute of Public Health NIH–NRI. Biuletyny, meldunki, informacje epidemiologiczne [cited 23.04.2026]. Available from URL: https://wwwold.pzh.gov.pl/oldpage/epimeld/index_p.html (in Polish).
  22. National Institute of Public Health NIH–NRI. Zachorowania na wybrane choroby zakaźne w Polsce od 1 stycznia do 31 marca 2026 r. oraz w porównywalnym okresie 2025 r. Warszawa: NIZP PZH–PIB; 2026 (in Polish).
  23. Statistics Poland. Bank Danych Lokalnych [cited 23.04.2026]. Available from URL: https://bdl.stat.gov.pl/bdl/dane/podgrup/temat# (in Polish).
  24. Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000; 18: S68–S70, doi: 10.1016/S0264-410X(99)00469-7.
  25. Magdzik W, Czarkowski MP. Zmiany w endemiczności wirusowego zapalenia wątroby typu A (WZW A) w Polsce. Przegl Epidemiol 2004; 58: 3–8 (in Polish).
  26. National Institute of Public Health NIH–NRI. Wirusowe zapalenie wątroby typu A (WZW A) [cited 23.04.2026]. Available from URL: https://epibaza.pzh.gov.pl/story/wirusowe-zapalenie-w%C4%85troby-typu-wzw (in Polish).
  27. Czarkowski MP, Cielebąk E, Staszewska-Jakubik E, et al. Choroby zakaźne i zatrucia w Polsce w 2017 roku. Warszawa: NIZP PZH–PIB; 2018 (in Polish).
  28. European Centre for Disease Prevention and Control. Hepatitis A – annual epidemiological report for 2017 [cited 23.04.2026]. Available from URL: https://www.ecdc.europa.eu/en/publications-data/hepatitis-annual-epidemiological-report-2017.
  29. Polański P, Kucharczyk B, Kondej B, et al. Hepatitis A in Poland in 2017 – epidemic increase cases. Przegl Epidemiol 2020; 73: 487–497, doi: 10.32394/pe.73.46.
  30. Polański P, Augustynowicz E. Szczepionka przeciw wzw A. Szczepienia.Info [Internet] 2026 Jan [cited 13.05.2026]. Available from URL: https://szczepienia.pzh.gov.pl/szczepionki/wzw-a/?strona=4#kto-i-kiedy-powinien-zostac-zaszczepiony-przeciw-wzw-a (in Polish).
  31. Duszczyk E, Wiercińska M. Szczepienie przeciwko WZW typu A. Med Prakt Szczepienia [Internet] 2023 Jul [cited 13.05.2026]. Available from URL: https://www.mp.pl/pacjent/szczepienia/szczepienia-i-szczepionki/66812,szczepienie-przeciwko-wzw-typu-a (in Polish).
  32. National Health Fund [Narodowy Fundusz Zdrowia]. Order No. 9/2026/DGL amending the order on the conditions for concluding and implementing contracts for the provision of recommended protective vaccinations in pharmacies. [Internet] 2026 [cited 13.05.2026]. Available from URL: https://www.nfz.gov.pl/zarzadzenia-prezesa/zarzadzenia-prezesa-nfz/zarzadzenie-nr-92026dgl,7913.html (in Polish).
  33. Obwieszczenie Marszałka Sejmu Rzeczypospolitej Polskiej z dnia 23 maja 2024 r. w sprawie ogłoszenia jednolitego tekstu ustawy o zapobieganiu oraz zwalczaniu zakażeń i chorób zakaźnych u ludzi [Act of 5 December 2008 on the Prevention and Control of Infections and Infectious Diseases in Humans] (Dz.U. 2024 poz. 924). Available from URL: https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20240000924 (in Polish).
  34. Rzymski P, Zarębska-Michaluk D, Genowska A, et al. Trends of hepatitis A virus infection in Poland: assessing the potential impact of the COVID-19 pandemic and war in Ukraine. Viruses 2024; 16: 469, doi: 10.3390/v16030469.
  35. Beauté J, Westrell T, Schmid D, et al. Travel-associated hepatitis A in Europe, 2009 to 2015. Euro Surveill 2018; 23, doi: 10.2807/1560-7917.ES.2018.23.22.1700583.
  36. Balogun O, Brown A, Angelo KM, et al. Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008–2020. J Travel Med 2022; 29: taac013, doi: 10.1093/jtm/taac013.
  37. European Centre for Disease Prevention and Control. Hepatitis A – annual epidemiological report 2022 [cited 20.04.2026]. Available from URL: https://www.ecdc.europa.eu/en/publications-data/hepatitis-annual-epidemiological-report-2022.

Copyright: © 2026 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Integrated with